The UK government announced on 23 October the creation of the AI Biosecurity Lab (AIBL). The new organisation will receive £100 million from the state budget (about $134 million); the project is backed by OpenAI, Anthropic and Google DeepMind. According to Bloomberg, it will be the world's first organisation dedicated to tackling risks at the intersection of AI and biology — a status also confirmed in the government's official press release.

Funding structure

On top of the government funding, two major AI companies have committed up to £200 million to the lab. OpenAI will provide £100 million in compute and model credits through its Rosalind Biodefense programme, plus trusted access to its most capable models. Anthropic will contribute up to £100 million in model credits, trusted access to its models and dedicated technical support. A footnote to the official statement says that together with the government funding and corporate commitments, the total project value will reach up to £300 million. The lab builds on Britain's broader biosecurity strategy, supporting existing national biosecurity centres and world-leading life sciences industry players with frontier AI capabilities.

"The AI Biosecurity Lab will be the world's first dedicated AI biosecurity organisation." — GOV.UK press release

The lab's mission

The lab is being established under the National AI Biosecurity Initiative. Its mission is to use frontier AI capabilities to build practical technical capacity for understanding, preventing, early-detecting and responding to biological threats. The first phase will focus on two tracks: early detection of emerging biological threats, and accelerating the development and testing of vaccines, therapeutics and other medical countermeasures. This will help respond faster to disease outbreaks and strengthen resilience to future biological risks. The lab's cutting-edge research will reinforce defences against large-scale biological risks amplified by AI advances.

Who is collaborating

Google DeepMind scientists and biosecurity experts will establish deep research collaborations with the lab; the company plans to offer trusted access to its most advanced Gemini models and specialised scientific models. Basecamp Research, one of Britain's leading companies in AI and life sciences, will provide access to its AI-biology models, technical capabilities and expertise to tackle priority biosecurity challenges.

Basecamp Research — a British AI-biology company — will contribute its models, technical capabilities and expertise to the lab for priority biosecurity challenges.

AIBL will operate as an independent, non-profit organisation designed to make the UK a global leader in AI-enabled biosecurity. It is modelled on the AI Security Institute: it will attract leading specialists from industry and academia and will have enough independence to move at the speed and focus of a frontier AI-biology company. A scientific advisory committee will be formed at the lab, drawn from academia, industry and the third sector; details will be announced later.

Because biosecurity sits at the heart of the lab's mission, it will maintain trusted partnerships with government agencies. Under the national initiative, AIBL will work jointly with the UK Health Security Agency (UKHSA), the Animal and Plant Health Agency (APHA), the Defence Science and Technology Laboratory (Dstl) and the life sciences sector. It will also collaborate with the Medicines and Healthcare products Regulatory Agency (MHRA) on preparedness for health emergencies and on regulating AI-developed medicines.

Background

The official statement notes that advances in AI are unlocking unprecedented opportunities for scientific discovery while reshaping the landscape of biological risks. Increasingly powerful systems accelerate research, deepen understanding of disease and support the discovery of new medical countermeasures — but may also lower barriers to harmful activity. The UK government therefore aims to fully harness AI's benefits while strengthening resilience to biological threats. The new lab's research will help increase the resilience of the UK and the world to large-scale biological risks amplified by advances in artificial intelligence.